Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2010

View Archived Issues

Dual IL-4/IL-13 receptor antagonist AER-003 reduces AHR in primates

Phase III data support use of mannitol test to identify EIB and asthma in children

Maraviroc analogue UK-484900 inhibits AHR in mice

Concert Pharmaceuticals discloses deuterated dual SV2A/Na channel blockers

Phase III data support icatibant safety and efficacy in acute HAE

Clinical data support combination of oxymetazoline and mometasone furoate for nasal congestion

Rigel identifies AXL kinase inhibitors for cancer therapy

BioDelivery Sciences presents update on BEMA Buprenorphine

Memory and Roche discover new PDE4 inhibitors

Neuraxon identifies nNOS inhibitors as analgesics

Bayer Schering claims new polo-like kinase 1 inhibitors

Antares completes enrollment in phase III Anturol trial in overactive bladder

EMA accepts voclosporin for regulatory review

Inovio to begin clinical trial of H5N1 flu DNA vaccine in Korea

InterMune submits MAA for pirfenidone for treatment of idiopathic pulmonary fibrosis

Synta resumes clinical development of elesclomol

Astellas commences tender offer to acquire OSI Pharmaceuticals

Shionogi and QuatRx to market and develop ospemifene

FDA reschedules meeting on ChemGenex's application for Omapro in CML

Renovo and Shire revise licensing deal for Juvista

FDA recommends approval of Bristol-Myers Squibb's belatacept

Celsion to begin phase II trial of ThermoDox and RFA for colorectal liver metastases

Orphan drug designation for Lithera's LIPO-102

Lundbeck inlicenses marketing rights to Azilect in Asian countries

Abbott and Enanta advance their hepatitis C collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...